Economics, Econometrics and Finance : Feb 2010 |
![]() |
Written by PORNTIP CHAICHOETCHUWONG |
Thursday, 11 March 2010 23:23 |
1. The price of innovation: new estimates of drug development costs Journal of Health Economics, Volume 22, Issue 2, March 2003, Pages 151-185 DiMasi, J.A.; Hansen, R.W.; Grabowski, H.G. Keywords: Innovation; R&D cost; Pharmaceutical industry; Discount rate; Technical success rates Cited By in Scopus (789) 2. Investor protection and corporate governance Journal of Financial Economics, Volume 58, Issue 1-2, January 2000, Pages 3-27 La Porta, R.; Lopez-de-Silanes, F.; Shleifer, A.; Vishny, R. Keywords: Investor, protection; Corporate governance; Law Cited By in Scopus (459) 3. The theory and practice of corporate finance: evidence from the field Journal of Financial Economics, Volume 60, Issue 2-3, May 2001, Pages 187-243 Keywords: Capital structure; Cost of capital; Cost of equity; Capital budgeting; Discount rates; Project valuation; Survey Cited By in Scopus (338) 4. Information asymmetry, corporate disclosure, and the capital markets: A review of the empirical disclosure literature Journal of Accounting and Economics, Volume 31, Issue 1-3, September 2001, Pages 405-440 Healy, P.M.; Palepu, K.G. Keywords: Reporting decisions; Voluntary disclosure Cited By in Scopus (259) 5. Capital markets research in accounting Journal of Accounting and Economics, Volume 31, Issue 1-3, September 2001, Pages 105-231 Kothari, S.P. Keywords: Capital markets; Financial reporting; Fundamental analysis; Valuation; Market efficiency Cited By in Scopus (199)
Data from October to December 2009 |
Last Updated on Sunday, 14 March 2010 17:59 |